IM Cannabis Corp C.IMCC

Alternate Symbol(s): IMCC

Healthcare

IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which has a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.

CSE:IMCC - Post by User

IM Cannabis Corp > IM Cannabis Heading To "Delistment Levels"

<< Previous

Bullboard Posts

Next >>

Post by NLMooseon Jun 10, 2022 11:23am

134 Views

Post# 34747168

IM Cannabis Heading To "Delistment Levels"

With IM Cannabis stock now close to $1 a share, investors need to address concerns about its performance before it falls below that critical level and risking delistment from the NASDAQ.

If nothing is done, IM Cannabis will become an "IM Waste Of Money"!!

<< Previous

Bullboard Posts

Next >>

The impact of Israel-Iran conflict on global markets